日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/07/24 | 1,795 | 1,817 | 1,766 | 1,816 | +22 | +1.2% | 169,000 |
2013/07/23 | 1,790 | 1,800 | 1,776 | 1,794 | +2 | +0.1% | 152,000 |
2013/07/22 | 1,755 | 1,794 | 1,735 | 1,792 | +37 | +2.1% | 178,000 |
2013/07/19 | 1,762 | 1,771 | 1,745 | 1,755 | -3 | -0.2% | 218,000 |
2013/07/18 | 1,759 | 1,769 | 1,748 | 1,758 | -1 | -0.1% | 137,000 |
2013/07/17 | 1,720 | 1,764 | 1,720 | 1,759 | +26 | +1.5% | 184,000 |
2013/07/16 | 1,733 | 1,754 | 1,728 | 1,733 | -5 | -0.3% | 104,000 |
2013/07/12 | 1,731 | 1,755 | 1,723 | 1,738 | +3 | +0.2% | 165,000 |
2013/07/11 | 1,715 | 1,749 | 1,710 | 1,735 | +1 | +0.1% | 146,000 |
2013/07/10 | 1,757 | 1,768 | 1,718 | 1,734 | -29 | -1.6% | 173,000 |
2013/07/09 | 1,756 | 1,779 | 1,750 | 1,763 | +7 | +0.4% | 227,000 |
2013/07/08 | 1,736 | 1,768 | 1,731 | 1,756 | +10 | +0.6% | 179,000 |
2013/07/05 | 1,740 | 1,755 | 1,731 | 1,746 | +6 | +0.3% | 177,000 |
2013/07/04 | 1,714 | 1,750 | 1,713 | 1,740 | +26 | +1.5% | 208,000 |
2013/07/03 | 1,735 | 1,738 | 1,710 | 1,714 | -51 | -2.9% | 241,000 |
2013/07/02 | 1,700 | 1,783 | 1,698 | 1,765 | +92 | +5.5% | 401,000 |
2013/07/01 | 1,640 | 1,688 | 1,633 | 1,673 | +21 | +1.3% | 147,000 |
2013/06/28 | 1,600 | 1,653 | 1,580 | 1,652 | +68 | +4.3% | 218,000 |
2013/06/27 | 1,543 | 1,592 | 1,527 | 1,584 | +34 | +2.2% | 193,000 |
2013/06/26 | 1,593 | 1,598 | 1,519 | 1,550 | -42 | -2.6% | 160,000 |
2013/06/25 | 1,614 | 1,635 | 1,551 | 1,592 | -61 | -3.7% | 254,000 |
2013/06/24 | 1,591 | 1,662 | 1,570 | 1,653 | +64 | +4% | 307,000 |
2013/06/21 | 1,559 | 1,600 | 1,522 | 1,589 | +1 | +0.1% | 225,000 |
2013/06/20 | 1,591 | 1,610 | 1,559 | 1,588 | -36 | -2.2% | 209,000 |
2013/06/19 | 1,610 | 1,627 | 1,592 | 1,624 | +55 | +3.5% | 196,000 |
2013/06/18 | 1,589 | 1,595 | 1,535 | 1,569 | -19 | -1.2% | 125,000 |
2013/06/17 | 1,516 | 1,592 | 1,516 | 1,588 | +43 | +2.8% | 178,000 |
2013/06/14 | 1,584 | 1,584 | 1,530 | 1,545 | +24 | +1.6% | 307,000 |
2013/06/13 | 1,597 | 1,597 | 1,520 | 1,521 | -33 | -2.1% | 347,000 |
2013/06/12 | 1,543 | 1,569 | 1,490 | 1,554 | +1 | +0.1% | 287,000 |
2013/06/11 | 1,489 | 1,570 | 1,488 | 1,553 | +65 | +4.4% | 230,000 |
2013/06/10 | 1,451 | 1,500 | 1,451 | 1,488 | +49 | +3.4% | 159,000 |
2013/06/07 | 1,396 | 1,500 | 1,393 | 1,439 | -17 | -1.2% | 333,000 |
2013/06/06 | 1,474 | 1,526 | 1,430 | 1,456 | -58 | -3.8% | 230,000 |
2013/06/05 | 1,505 | 1,562 | 1,505 | 1,514 | -7 | -0.5% | 172,000 |
2013/06/04 | 1,527 | 1,540 | 1,502 | 1,521 | -46 | -2.9% | 237,000 |
2013/06/03 | 1,592 | 1,645 | 1,560 | 1,567 | -38 | -2.4% | 290,000 |
2013/05/31 | 1,639 | 1,645 | 1,592 | 1,605 | +11 | +0.7% | 203,000 |
2013/05/30 | 1,638 | 1,661 | 1,581 | 1,594 | -46 | -2.8% | 222,000 |
2013/05/29 | 1,614 | 1,668 | 1,595 | 1,640 | +61 | +3.9% | 256,000 |
2013/05/28 | 1,580 | 1,605 | 1,567 | 1,579 | -43 | -2.7% | 225,000 |
2013/05/27 | 1,633 | 1,672 | 1,586 | 1,622 | -4 | -0.2% | 293,000 |
2013/05/24 | 1,581 | 1,681 | 1,578 | 1,626 | +12 | +0.7% | 390,000 |
2013/05/23 | 1,728 | 1,740 | 1,614 | 1,614 | -85 | -5% | 443,000 |
2013/05/22 | 1,712 | 1,715 | 1,686 | 1,699 | -27 | -1.6% | 276,000 |
2013/05/21 | 1,729 | 1,757 | 1,720 | 1,726 | -20 | -1.1% | 297,000 |
2013/05/20 | 1,831 | 1,831 | 1,744 | 1,746 | +35 | +2% | 409,000 |
2013/05/17 | 1,695 | 1,720 | 1,628 | 1,711 | +76 | +4.6% | 422,000 |
2013/05/16 | 1,673 | 1,690 | 1,598 | 1,635 | -77 | -4.5% | 363,000 |
2013/05/15 | 1,667 | 1,722 | 1,667 | 1,712 | +46 | +2.8% | 494,000 |
2901~
2950
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム